Please login to the form below

Not currently logged in
Email:
Password:

hepatitis C

This page shows the latest hepatitis C news and features for those working in and with pharma, biotech and healthcare.

Riva leaves Gilead to head Glenmark’s innovation spin-off

Riva leaves Gilead to head Glenmark’s innovation spin-off

Faced with contraction in its hepatitis C franchise, many expect O’Day to draw on his experience as Roche’s R&D to expand further into cancer therapies, a process which

Latest news

More from news
Approximately 97 fully matching, plus 245 partially matching documents found.

Latest Intelligence

  • The race for a HIV ‘cure’ The race for a HIV ‘cure’

    Most of our medicines in Europe are available at the same time, at generic prices, in Africa – in hepatitis C, the drugs are available earlier in Africa than Europe because of

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    Meanwhile, the pharma industry is hitting new heights in drug innovation, including cures for diseases such as hepatitis C, haemophilia and huge progress in cancer and cell and gene therapy - but

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    on hepatitis C treatments and the recent introduction of the Budget Impact Test.

  • No incentive for a cure No incentive for a cure

    Hepatitis C virus treatments like Maviret from AbbVie, which cures people with hard-to-treat genotype 3 after an 8. ... This is the route the NHS in the UK has taken with innovative hepatitis C treatments; it will only pay for the medication if a patient

  • IQVIA: The High IQ Approach of Human Data Science IQVIA: The High IQ Approach of Human Data Science

    Therapeutic advances during that same period have been remarkable; who would have thought we’d find a cure for hepatitis C, or see immunotherapy transform outcomes in cancer care?

More from intelligence
Approximately 2 fully matching, plus 33 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics